Refresh

Glenmark Life Sciences Ltd. - Research Center

543322 GLS Group (A) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

2,161.22 2,123.21 1,885.17 1,537.31 886.42
Expenses

Material consumed

1,028.87 1,055.04 913.87 699.95 359.55

Manufacturing expenses

118.08 103.57 76.01 79.43 56.79

Personnel expenses

180.18 168.72 149.13 142.28 106.28

Selling expenses

- - - - -

Adminstrative expenses

191.80 179.82 155.08 143.70 116.09

Expenses capitalised

- - - - -

Cost of sales

1,518.93 1,507.15 1,294.09 1,065.35 638.70

Operating profit

642.29 616.06 591.07 471.96 247.72

Other recurring income

28.96 14.70 0.81 11.99 0.44

Adjusted PBDIT

671.25 630.76 591.89 483.95 248.16

Financial expenses

0.55 27.96 87.55 33.52 0.61

Depreciation

42.09 37.88 33.39 29.37 19.26

Other write offs

- - - - -

Adjusted PBT

628.61 564.93 470.94 421.07 228.30

Tax charges

161.65 146.20 119.36 107.97 32.71

Adjusted PAT

466.96 418.72 351.58 313.10 195.59

Non recurring items

-0.29 0.10 -0.53 0.47 0.11

Other non cash adjustments

- - - - -

Reported net profit

466.67 418.82 351.06 313.57 195.70

Earnigs before appropriation

1,488.02 1,169.61 750.79 399.73 194.29

Equity dividend

385.96 128.65 - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

1,102.06 1,040.95 750.79 399.73 194.29
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com